Healthcare's share of the global PE and VC deal count will likely continue decreasing in 2024, according to a new Pitchbook report. The report also predicted that generative AI and surgical robotics will continue to be hot areas of interest for investors, and that there will be at least three digital health IPOs next year.
As macroeconomic forces continue to negatively impact the healthcare sector, health tech experts predict that 2023 will be another slow year for the IPO market. However, they think consolidation deals will continue to be a constant, according to a new report.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Large corporations don't hold all the bargaining power in the world of medtech M&A these days, says a corporate venture capitalist with Boston Scientific.
After a relatively quiet IPO market, 2019 has emerged as the year of the digital health IPO with Health Catalyst, Livongo Health, Phreesia, and Change Healthcare all going public earlier this year and Peloton going public in October. Will this last?